Navigation Links


Found in Biological Technology

Muscular protein bond -- strongest yet found in nature

A research collaboration between Munich-based biophysicists and a structural biologist in Hamburg is helping to explain why our muscles, and those of other animals, don't simply fall apart under stress. Their findings may have implications for fields as diverse as medical research and nanotechnolo...

Novel gene found for dilated cardiomyopathy

Researchers in the Heart Institute at Cincinnati Children's Hospital Medical Center have discovered a novel gene responsible for heart muscle disease and chronic heart failure in some children and adults with dilated cardiomyopathy (DCM). Mutations in the ANKRD1 gene may cause DCM, which is the...

"Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart

After a six-year battle with heart disease that included numerous medications, trips to the emergency room and surgery to implant a pacemaker, 40-year-old Jim Fijalkovich found himself in the Intensive Care Unit at an Ohio hospital. Both sides of his heart were dying and he was in desperate need ...

Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties

MINNEAPOLIS, July 3 /PRNewswire/ -- The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE(R) possessed DNA protective anti-mutagenic ...

Agent in red wine found to keep hearts young

MADISON - How, scientists wonder, do the French get away with a clean bill of heart health despite a diet loaded with saturated fats? The answer to the so-called "French paradox" may be found in red wine. More specifically, it may reside in small doses of resveratrol, a natural constituent of g...

Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes

BOSTON, May 19 /PRNewswire/ -- Replikins Ltd. has found that very high concentrations of its replikin genetic sequences are found in the trypanosomes that are the infectious agents in malaria. The levels found by the company are in fact the highest replikin concentrations observed to date in a...

University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland

CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging services ...

DNA sensors found to be an effective artificial nose

In designing artificial noses modeled after biological olfaction, the challenge has been to generate a similarly large sensor repertoire with the requisite combinatorial complexity to detect odors in the real world. A further requirement is that the sensors can be manufactured with exact chemical ...

New property found in ancient mineral lodestone

HOUSTON -- Dec. 17, 2007 -- Using the latest methods for nanofabrication, a team led by Rice University physicists has discovered a surprising new electronic property in one of the earliest-known and most-studied magnetic minerals on Earth -- lodestone, also known as magnetite. By changing the ...

New use for stem cells found in war on terrorism

For more than a decade, Steve Stice has dedicated his research using embryonic stem cells to improving the lives of people with degenerative diseases and debilitating injuries. His most recent discovery, which produces billions of neural cells from a few stem cells, could now aid in national secur...

PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty

- Despite outcome, CEO Mark McDade to resign for personal reasons - FREMONT, Calif., Aug. 20 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced that a three-month internal investigation of the company's chief executive officer (CEO), Mark McDade, found no cr...

Beyond associations: Colorectal cancer culprit found

Genetics plays a key role in determining risk for colorectal cancer, the second leading cause of cancer-related deaths in the United States. Several common genetic markers have been found to be associated with the disease, but finding the biological events that lead to cancer can be much more dif...

Genetic pathway critical to disease, aging found

MADISON -- The same chemical reaction that causes iron to rust plays a similarly corrosive role in our bodies. Oxidative stress chips away at healthy cells and is a process, scientists know, that contributes to a host of diseases and conditions in humans ranging from Alzheimer's, heart disease and...

UW Alzheimer's researchers found company; privacy law; Science Expeditions

Jeff Johnson, a UW-Madison scientist, and his colleagues want to develop a commercial drug for Alzheimer's disease at their new company in Madison, named Mithridion. Also, Wisconsin legislators are introducing a new computer privacy law aimed at making companies notify people of database breaches, ...

UW scientist, former WiCell director found stem cell company

Madison, Wis. - It's not too early to gauge the level of investor interest in Stemina Biomarker Discovery, Inc., a new company formed by Beth Donley and University of Wisconsin-Madison stem cell scientist Gabriela Cezar. Donley already is rubbing elbows with interested investors, particularl...

Windows image bug patched, but more found

Microsoft has patched the Windows vulnerability that could allow malicious programs to be installed when users viewed pictures on their computers. But security experts say the same part of Windows has even more problems than previously thought, opening up more holes. Giving in to pressure from u...

Growth spurts

...eng, a chemist in Alivisatos' research group, who was the lead author on a paper that reported these results in the journal Science. "In our study, we found that coalescence events are frequently involved in the early stage of nanocrystal growth and yet monodisperse nanocrystals are still formed." Says ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information con...

Viral Genetics Creates Subsidiary to Develop Cancer Therapy

...uption technology" (MDT), which focuses on blocking a tumor cell's ability to generate energy from glucose or from fatty acids. That process has been found in animal studies to not only directly cause cancer cells to die but also to synergize with existing treatments such as chemotherapy and radiation the...

ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA

...interest to both academic institutions and biotech companies." Julie Rasku, a scientist with ALPCO Diagnostics' development team assures us, "I found the mouse adiponectin assay to be highly reproducible with low variance. It is a reliable method to determine mouse adiponectin levels." The Mouse HMW...

OncoGenex Reports Second Quarter 2009 Financial Results

...day to provide a business update and discuss the first quarter results. A live webcast will be available through the Events and Presentations Web page found in the Investor Relations section of the OncoGenex Web site at www.ir.oncogenex.com . Alternatively, you may access the live conference call by diali...

Telik Announces Second Quarter 2009 Financial Results

... regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

...ntly decreased the proportion of cancer stem cells found in tumors compared to chemotherapy alone. In addi...ificantly decreases the ratio of cancer stem cells found in colon and breast tumors. Notably, treatment wi...ed to increase the ratio of tumorigenic stem cells found in colon and breast tumors. Further, OMP-21M18 wa...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

...e the side effects triggered by the much larger natural biologic molecules. Out of the more than one million small molecules he studied, he ultimately found 4 that protected the cells and that had profiles suitable for further drug development. Once these molecules were identified, Dr. Longo formed Pharmat...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... The conference call will also be web cast and can be accessed from the company's website at www.PharmAthene.com . A link to the web cast may be found under the Investor Relations section of the website. The web cast will be available for 30 days, or until approximately September 12, 2009. ...

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

...in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www.orexigen.com . ...

ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12

...cals is a biopharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's web site at www.adventrx.com . ...

ADVENTRX Pharmaceuticals Announces Financing

...als is a biopharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's web site at www.adventrx.com . Forward Looking Statement ADVENTRX cautions you that statements included in this ...

CapitalBio Corporation and VigeneTech Inc. Have Announced the Launch of a Fully Integrated Microarray Solution Platform

...ed analysis possibilities. This fully customized application brings image analysis to a new level of control. Irregular spots and offset spots are all found easily and then analyzed with the highest accuracy." "Sensitivity, accuracy and reliability are the key drivers for any microarray technology t...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...ecurring and non-recurring, that Shire's management believes are not related to the core performance of Shire's business. A list of these items can be found on pages 26-27. PRODUCT LAUNCHES Subject to obtaining the relevant regulatory/governmental approvals, product launches planned over the ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing

...otocol Ygiene(TM) Hospital Grade Antimicrobial was found to be completely non-corrosive to steel. M... test, Ygiene(TM) Hospital Grade Antimicrobial was found to be completely inert and not corrosive while all of the following products tested were found to be corrosive: Lysol(R) Disinfectant All Purpose...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

...hich has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http://www.optimerpharma.com . Forward-looking Statements Statements included in this press release that are not a description of h...

Plastics that convert light to electricity could have a big impact

...ectricity and can be easily manufactured. A research team headed by David Ginger, a University of Washington associate professor of chemistry, has found a way to make images of tiny bubbles and channels, roughly 10,000 times smaller than a human hair, inside plastic solar cells. These bubbles and chann...

Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient

...he availability of Compounded Mupirocin Liquid. Mupirocin is typically only found in ointment form. ASL's compound does not contain any added ingredients, on...n. ASL's compounded mupirocin liquid does not contain the other ingredients found in the ointment. ASL's formula only contains pure mupirocin, sterile water ...

Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure

...de in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide. More information on Nile can be found at http://www.nilethera.com . Safe Harbor Paragraph for Forward-Looking Statements : This press release contains forward-looking st...

Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11

...primary cause of cervical cancer. QIAGEN employs more than 3,100 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com . (Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/pro...

Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference

...hich has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http:// www.optimerpharma.com . Contacts Optimer Pharmaceuticals, Inc. Christina Donaghy, Corporate Communications Manager ...

OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.

...aterially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly upd...

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009

...T. Interested parties can access the call by dialing (800) 860-2442 or (412) 858-4600, or can listen via a live Internet web cast, which can be found at http://bionovo.com/investors/events . A replay of the call is available via web cast at http://bionovo.com/investors/events for 30 days ...

Cardinal Health Completes Biotech Acquisition

...ide. Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at www.cardinalhealth.com . ...
Other TagsLogicalLogicalLogicalLogicalLogicalLogicalCatheterization
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... can undergo a personality change in warmer water, according to ... some species more aggressive. , Experiments with two species of ... the first time that some reef fish are either consistently ... even more marked as water temperatures rise. , A slight ...
(Date:12/3/2009)... UPTON, NY A team of scientists from the ... University, and the Indian Institute of Science has made ... genetic information in DNA that is necessary to carry ... December 1, 2009 edition of Nature Structural & ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 1Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 2Laboratory Test May Predict Effectiveness of ERBITUX 28R 29 for Individual Colorectal Cancer Patients 12384 3Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 1Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 2Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 3Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 4Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 5Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 6Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 7Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 8Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 9Cimzia 28R 29 28certolizumab pegol 29 Provides Long Term Remission and Response Rates in Infliximab Refractory Crohns Patients 12382 10Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 1Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 2Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 3Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 4Shire Presented Results of a New Database Analysis on Lialda 28R 29 28Mesalamine 29 and Other 5 ASAs for Ulcerative Colitis at Digestive Disease Week 4503 5
(Date:12/6/2009)... Dec. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... from the pivotal Phase 2b 003-A1 study, known ... well-tolerated in heavily pre-treated relapsed and refractory multiple ... the ASH/ASCO Joint Symposium at the 51st annual ... in New Orleans. Enrollment in this trial is ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/6/2009)... says dangerous substances such as asbestos have been found in toys ... ... (PRWEB) December 6, 2009 -- As parents shop for children,s toys ... recalls due to lead paint or asbestos contamination, says a New ... emergency rooms each year due to toy-related injuries,” says Joseph W. ...
(Date:12/5/2009)... What: Cuts for a Cause ,, Why: ... and other terminal illnesses affecting children. All proceeds from each ... Research Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, ... in Falls Church for all guests. Hoa Lai, a DJ ...
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
Other Contentspericardiocentesisperineumpercutaneouspercutaneouspercutaneouspercutaneouspercutaneouspepsinpepticpepticpercussionperforationperforationperforationmovementmovementmovementmovementmovementmovementmovementmovementmovementmovement